X0609 4 2026-09-17 0 0001513525 ADIAL PHARMACEUTICALS, INC. ADIL 0002042847 Young Wendy B. false C/O ADIAL PHARMACEUTICALS, INC. 4870 SADLER ROAD, SUITE 300 GLEN ALLEN VA 23060 1 0 0 0 0 Stock Option (Right to Buy) 2.98 2026-09-17 4 A 0 25666 0 A 2036-06-12 Common Stock 25666 25666 D On June 11, 2026, the Issuer's board of directors approved the option grant issued to the Reporting Person on June 12, 2026, which grant was subject to stockholder approval of an amendment to the Issuer's 2017 Equity Incentive Plan to increase the number of shares authorized for issuance thereunder. The Issuer's stockholders approved the plan amendment on September 17, 2026 ("Stockholder Approval Date"). 2,138 shares subject to the stock option vested on the Stockholder Approval Date and the remaining 23,528 shares subject to the stock option shall vest in substantially equal installments over a 33-month period, beginning on October 12, 2026. /s/ Matthew Davidson, Attorney-in-Fact 2026-09-21